164861-42-1Relevant articles and documents
Reversible inhibitors of the gastric (H+/K+)-ATPase. 4. Identification of an inhibitor with an intermediate duration of action
Leach,Brown,Ife,Keeling,Parsons,Theobald,Wiggall
, p. 2748 - 2762 (2007/10/03)
3-Acyl-4-(arylamino)quinolines were previously identified as gastric (H+/K+)-ATPase inhibitors, and clinical efficacy has been demonstrated for compound 3 (SK and F 96067). In the present study the further structure- activity relatio